Skip to main content

Phase I study of intraarterial mitomycin-c for recurrent intracerebral tumors

  • Chapter
Biology of Brain Tumour

Abstract

Seventeen patients with intracerebral neoplasms were treated with intra-arterial mitomycin-c 7.5–18 mg/m2 at 6–9 week intervals. Most were heavily pretreated. Three of 8 evaluable patients with brain metastases, a single patient with a primitive neuroectodermal tumor, and 0 of 6 with glioblastomas responded to treatment. The activity of this regimen to date has been impressive considering the patient population treated. Neurological and ocular toxicity were dose-limiting. We recommend a mitomycin-c dose of 15 mg/m2 every 6–9 weeks for further studies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fenstermacher J, Cowles A: Theoretic Limitations of Intracarotid Infusions in Brain Tumor Chemotherapy. Cancer Treat Rep 61: 519–526, 1977

    PubMed  CAS  Google Scholar 

  2. Chen HAG, Gross J: Intra-arterial Infusion of Anticancer Drugs: Theoretic Aspects of Drug Delivery and Review of Responses. Cancer Treat Rep 64: 31–40, 1980

    PubMed  CAS  Google Scholar 

  3. Collins J: Phamracologic Rationale for Regional Drug Delivery. J Clin Oncol 2: 498–504, 1984

    PubMed  CAS  Google Scholar 

  4. Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallace S, Chuang V, Calvo III D, Samuels M, Bonura J, Loo TL: Clinical Pharmacology of Intra-arterial Cis-diammine Dichloroplatinum (II). Cancer Research 43: 917–920, 1983

    PubMed  CAS  Google Scholar 

  5. Stewart DJ: Novel Modes of Chemotherapy Administration. Rosenblum ML, Wilson CB (eds). Progress in Experimental Brain Tumor Research. S Kargel Med & Scientific Publishers. Basel/Switzerland. Vol 28, pp 32–50, 1984

    Google Scholar 

  6. Ensminger W, Gyves J: Clinical Pharmacology of Hepatic Arterial Chemotherapy. Semin Oncol 10: 176–182, 1983

    PubMed  CAS  Google Scholar 

  7. Stewart DJ, Benjamin RS, Luna M, Seifert WE, Loo TL: Human Tissue Distribution of Platinum After Cis-diamminedichloroplatinum. Cancer Chemother & Pharm 10: 51–54, 1982

    CAS  Google Scholar 

  8. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human Central Nervous System Distribution of Cis-Diamminedichloroplatinum and Use as a Radiosensitizer in Malignant Brain Tumors. Cancer Research 2: 2474–2479, 1982

    Google Scholar 

  9. Levin V, Kabra P, Freeman-Dove M: Pharmacokinetics of intra-carotid Artery 14C-BCNU in the Squirrel Monkey. J Neurosurg 48: 587–593, 1978

    Article  PubMed  CAS  Google Scholar 

  10. Crooke S, Bradner W: Mitomycin-C: A Review. Cancer Treat Rev 3: 121–139, 1976

    Article  PubMed  CAS  Google Scholar 

  11. Anderson T, Andreasson L, Biorklund A, Brismar J, Elver A, Eneroth C, Hellekant C, Landberg T, Mattisson W: Intra-arterial Chemotherapy of Malignant Head and Neck Tumors with Superselective Angiographic Technique. Acta Otolaryngol 360 (Suppl): 167–170, 1979

    Google Scholar 

  12. Misra NC, Jaiswal M, Singh R, Das B: Intrahepatic Arterial Infusion of Combination of Mitomycin-C and 5-Fluorouracil in the Treatment of Primary and Metastatic Liver Carcinoma. Cancer 39: 1425–1429, 1977

    Article  PubMed  CAS  Google Scholar 

  13. Den Hartigh J, McVie J, Van Oort J, Pinedo H: Pharmacokinetics of Mitomycin-C in Humans. Cancer Res 43: 5017–5021, 1983

    Google Scholar 

  14. Takakura K: Chemotherapy of Metastatic Brain Tumors, with Particular Reference to Continuous Intracranial Infusion of Mitomycin-C and a Radiosensitizing Agent, BUDR. Jpn J Cancer Clin 17: 263–268, 1971

    CAS  Google Scholar 

  15. Stewart DJ, Grahovac Z, Benoit B, Addison D, Richard MT, Dennery J, Hugenholtz H, Russel N, Peterson E, Maroun JA, Vandenberg T, Hopkins HS: Intracarotid Chemotherapy with a Combination of BCNU, Cisplatin and VM-26 in the Treatment of Primary and Metastatic Brain Tumors. Neurosurgery 15: 828–833, 1984

    Article  PubMed  CAS  Google Scholar 

  16. Lehane D, Ehni G, Moiel R, Bryon R, Horowitz B, DeSantos L, Aldama-Luebert A, Zublir M, Rudolph L, Lane M: Adjuvant Therapy for Malignant Gliomas (MG) Using Intra-Arterial (IA) Cisplatinum (CP), Radiation Therapy (RT) and CCNU. Proc Am Soc Clin Oncol 2: 236, 1983 (abstr)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinas Nijhoff Publishers, Boston

About this chapter

Cite this chapter

Stewart, D.J. et al. (1986). Phase I study of intraarterial mitomycin-c for recurrent intracerebral tumors. In: Walker, M.D., Thomas, D.G.T. (eds) Biology of Brain Tumour. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2297-9_65

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2297-9_65

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9415-3

  • Online ISBN: 978-1-4613-2297-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics